The lack of canonical HH-GLI signaling in these cells and our previous findings of potential SHH-N and ERα interactions21, motivated us to investigate whether SHH-N can non-canonically bind and activate the AR in prostate cancer cells. This evidence concerns the gene GLI1 and prostate carcinoma.